e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Smoking cessation with special focus on COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nicotine replacements, bupropion and psychoactive groups in the antismoking outclinic center
M. Del Donno, P. Granauro, A. Verduri, G. Giucastro, F. Argentieri, A. Chetta, D. Olivieri (Parma, Italy)
Source:
Annual Congress 2002 - Smoking cessation with special focus on COPD
Session:
Smoking cessation with special focus on COPD
Session type:
Poster Discussion
Number:
3581
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Del Donno, P. Granauro, A. Verduri, G. Giucastro, F. Argentieri, A. Chetta, D. Olivieri (Parma, Italy). Nicotine replacements, bupropion and psychoactive groups in the antismoking outclinic center. Eur Respir J 2002; 20: Suppl. 38, 3581
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Nicotine craving before and after use of NRT in hospital inpatients
Source: Annual Congress 2007 - The versatile aspects of nicotine addiction
Year: 2007
Pharmacological treatments for tobacco dependence
Source: Eur Respir Rev 2008; 17: 192-198
Year: 2008
Clinical experience from a smokers clinic combining bupropion and nicotine gum
Source: Annual Congress 2010 - Smoking cessation interventions
Year: 2010
Experiencing bupropion hydrochloride in smoking cessation
Source: Eur Respir J 2004; 24: Suppl. 48, 156s
Year: 2004
Nicotine dependence levels among e-cigarettes users
Source: International Congress 2019 – From the epidemiology of tobacco/electronic nicotine delivery system use to control and prevention of tobacco use
Year: 2019
Harm reduction in difficult-to-stop smokers
Source: Annual Congress 2005 - MP16 - Harm reduction in difficult-to-stop smokers
Year: 2005
Clinical experience from a smokers clinic combining bupropion and nicotine patch
Source: Annual Congress 2010 - Smoking cessation interventions
Year: 2010
A pharmacological with nicotine or bupropion versus an integrated pharmacological and psychological program for smoking cessation
Source: Eur Respir J 2002; 20: Suppl. 38, 579s
Year: 2002
Clinical experience from a smokers clinic combining varenicline and nicotine gum
Source: Annual Congress 2010 - Smoking related disorders and smoking cessation
Year: 2010
Cannabis use is associated with reduced harm perception towards illicit drugs and experimentation with new psychoactive substances among European adolescents and young adults
Source: International Congress 2015 – Epidemiology, public health and economics of tobacco
Year: 2015
Patients perceptions of nicotine replacement therapy (NRT) and smoking cessation services available in their area
Source: Eur Respir J 2001; 18: Suppl. 33, 167s
Year: 2001
Bupropion together with cognitive-conductual therapy (CBT) is an alternative for a long-term abstinence of smoking
Source: Annual Congress 2013 –Smoking cessation for healthy and non-healthy smokers
Year: 2013
Smoking habits and degree of nicotine addiction anong physicians
Source: Eur Respir J 2001; 18: Suppl. 33, 446s
Year: 2001
Still very few smokers are prescribed smoking cessation medications
Source: ISSN=ISSN 1810-6838, ISBN=, page=172
Year: 2005
Improvement of quit smoking rate by combining varenicline and nicotine replacement therapy
Source: Annual Congress 2009 - Smoking cessation
Year: 2009
Pharmacological treatment for smoking cessation
Source: Eur Respir Mon; 2008: 42: 74–97
Year: 2008
Is NRT in combination with other drugs more effective than NRT alone in smoking cessation?
Source: ISSN=ISSN 1810-6838, ISBN=, page=246
Year: 2005
Varenicline x combination of nicotine patch and bupropione: results of a smoking cessation private program
Source: Annual Congress 2009 - Smoking cessation
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept